Changes in Serum Uteroglobin Level in Type 2 Diabetes Mellitus Patients

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Oct 15

PMID 39403586

Authors

Joung Youl Lim

Sang-Hyeon Ju

Ji Min Kim

Hyon-Seung Yi

Ju Hee Lee

Hyun Jin Kim

Bon Jeong Ku

Kyong Hye Joung

Affiliations

Soon will be listed here.

Abstract

Background: Uteroglobin is a multifunctional protein with anti-inflammatory properties. Studies have revealed the importance of inflammation in type 2 diabetes mellitus (T2D) pathogenesis. Here, we investigated the relationship between uteroglobin and T2D.

Methods: We performed diagnostic tests for diabetes in subjects who had not been diagnosed with or treated for T2D. We established three groups, containing those with normal glucose tolerance (NGT), prediabetes and T2D, consisting of 80 people each, and compared their uteroglobin levels. In addition, 28 patients newly diagnosed with T2D were treated with metformin for 12 weeks, and 63 patients newly diagnosed with dyslipidaemia during the treatment for T2D were treated with statin for 12 weeks.

Results: This study showed that uteroglobin levels were significantly lower in prediabetes and T2D groups than in the NGT group. Uteroglobin levels were not significantly correlated with other metabolic parameters, except BMI, HOMA-β and eGFR. In the group treated with metformin or statin, uteroglobin levels increased after treatment compared to before treatment.

Conclusions: Uteroglobin is a sensitive factor that was decreased even in prediabetes and increased upon treatment with drugs with anti-inflammatory effects. Uteroglobin is a potential early biomarker that reflects a chronic inflammatory condition in T2D.

References

Jackson B, Thompson D, Wright M, McAndrews M, Bernard A, Nebert D . Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily. Hum Genomics. 2011; 5(6):691-702. PMC: 3251818. DOI: 10.1186/1479-7364-5-6-691. View

Ungaro R, Chang H, Cote-Daigneault J, Mehandru S, Atreja A, Colombel J . Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease. Am J Gastroenterol. 2016; 111(10):1416-1423. DOI: 10.1038/ajg.2016.233. View

Liberale L, Carbone F, Montecucco F, Sahebkar A . Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms. Int J Biochem Cell Biol. 2020; 122:105735. DOI: 10.1016/j.biocel.2020.105735. View

Matsushita K, Mahmoodi B, Woodward M, Emberson J, Jafar T, Jee S . Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012; 307(18):1941-51. PMC: 3837430. DOI: 10.1001/jama.2012.3954. View

Kahnert K, Andreas S, Kellerer C, Lutter J, Lucke T, Yildirim O . Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment. Sci Rep. 2022; 12(1):1435. PMC: 8792053. DOI: 10.1038/s41598-022-05276-x. View

Khan S, Ilies M . The Phospholipase A2 Superfamily: Structure, Isozymes, Catalysis, Physiologic and Pathologic Roles. Int J Mol Sci. 2023; 24(2). PMC: 9862071. DOI: 10.3390/ijms24021353. View

Nigam M, Mishra A, Kumar Deb V, Dimri D, Tiwari V, Bungau S . Evaluation of the association of chronic inflammation and cancer: Insights and implications. Biomed Pharmacother. 2023; 164:115015. DOI: 10.1016/j.biopha.2023.115015. View

Tseng C . Metformin's effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study. Front Pharmacol. 2022; 13:799290. PMC: 9355151. DOI: 10.3389/fphar.2022.799290. View

Choi J, Lee K, Moon J, Chon S, Kim D, Kim H . 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association. Diabetes Metab J. 2023; 47(5):575-594. PMC: 10555541. DOI: 10.4093/dmj.2023.0282. View

10.

Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H . Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014; 5(8):927-46. PMC: 4258672. View

11.

Levine C, Gewolb I, Allen K, Welch R, Melby J, Pollack S . The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome. Pediatr Res. 2005; 58(1):15-21. DOI: 10.1203/01.PDR.0000156371.89952.35. View

12.

Akash M, Rehman K, Chen S . Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2012; 114(3):525-31. DOI: 10.1002/jcb.24402. View

13.

Lee D, Yang S, Kim H, Joo K, Lim C, Chae D . Recombinant uteroglobin prevents the experimental crescentic glomerulonephritis. Kidney Int. 2004; 66(3):1061-7. DOI: 10.1111/j.1523-1755.2004.00855.x. View

14.

Cai X, Zhang Y, Li M, Wu J, Mai L, Li J . Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020; 370:m2297. PMC: 7362233. DOI: 10.1136/bmj.m2297. View

15.

Suh S, Kim K . Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment. Diabetes Metab J. 2020; 43(6):733-743. PMC: 6943263. DOI: 10.4093/dmj.2019.0177. View

16.

Rohm T, Meier D, Olefsky J, Donath M . Inflammation in obesity, diabetes, and related disorders. Immunity. 2022; 55(1):31-55. PMC: 8773457. DOI: 10.1016/j.immuni.2021.12.013. View

17.

Demircioglu Kilic B, Buyukcelik M, Balci S, Pehlivan S, Kul S, Col N . Uteroglobin gene polymorphism (G38A) may be a risk factor in childhood idiopathic nephrotic syndrome. Pediatr Nephrol. 2017; 33(2):295-303. DOI: 10.1007/s00467-017-3800-7. View

18.

Tseng C . Metformin and risk of chronic obstructive pulmonary disease in diabetes patients. Diabetes Metab. 2018; 45(2):184-190. DOI: 10.1016/j.diabet.2018.05.001. View

19.

Zhang N, Wang H, Xie Q, Cao H, Wu F, Di Wu D . Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma. Oncol Lett. 2019; 18(1):169-180. PMC: 6539486. DOI: 10.3892/ol.2019.10300. View

20.

Lombardi J, Naji M, Larson R, Ryan S, Naji A, Koeberlein B . Adenoviral mediated uteroglobin gene transfer to the adventitia reduces arterial intimal hyperplasia. J Surg Res. 2001; 99(2):377-80. DOI: 10.1006/jsre.2001.6209. View